Page last updated: 2024-09-04

docetaxel anhydrous and Chemotherapy-Induced Febrile Neutropenia

docetaxel anhydrous has been researched along with Chemotherapy-Induced Febrile Neutropenia in 29 studies

Research

Studies (29)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	25 (86.21)	24.3611
2020's	4 (13.79)	2.80

Authors

Authors	Studies
Hirahara, N; Hyakudomi, R; Ishitobi, K; Kaji, S; Matsubara, T; Tajima, Y; Takai, K; Uchida, Y; Yamamoto, T	1
Inagaki, T; Kin, M; Kogo, M; Murakami, M; Otsuka, K; Sato, M	1
Baas, IO; van der Wall, E; van Dooijeweert, C	1
Hoshina, H; Takei, H	1
Asao, T; Hara, K; Hisada, T; Imai, H; Jingu, A; Kaira, K; Kasahara, N; Kitahara, S; Koga, Y; Kuwako, T; Maeno, T; Masuda, T; Mori, K; Naruse, I; Sakurai, R; Sunaga, N; Tsukagoshi, Y; Tsurumaki, H; Yatomi, M	1
Imamura, CK; Kenmotsu, H; Murakami, H; Naito, T; Nakashima, K; Omori, S; Ono, A; Taira, T; Takahashi, T; Tanigawara, Y; Wakuda, K	1
Bossé, D; Canil, C; Koczka, K; Kushnir, I; Ong, M; Reaume, MN; Sabri, E	1
Ikari, Y; Imanishi, Y; Ito, F; Mikoshiba, T; Nakahara, N; Ogawa, K; Ozawa, H; Saito, S; Sekimizu, M; Watanabe, Y	1
Beith, J; Boyle, FM; Chen, TYT; Currow, DC; Della-Fiorentina, SA; Johnston, A; Lin, E; Moylan, EJ; Tervonen, HE	1
Daiko, H; Hatogai, K; Kawasaki, T; Kojima, T; Maki, Y; Mochizuki, N; Nomura, H; Saito, S; Tanaka, M	1
Chiarotto, JA; Dranitsaris, G	1
Cho, H; Inohara, H; Nakahara, S; Takenaka, Y; Yamamoto, M; Yamamoto, Y	1
Awada, Z; Bazarbachi, A; El-Saghir, NS; Haider, S; Salem, Z; Shamseddine, A; Taher, A; Tfayli, A; Zgheib, NK	1
Cantin, G; Côté, I; Desbiens, C; Doyle, C; Hogue, JC; Leblond, AF; Lemieux, J; Poirier, B; Poirier, E; Provencher, L	1
Ali, Z; Malik, Z; Misra, V; Mullard, AP; O'Reilly, SM; Sumra, P	1
Chia, VM; Langeberg, WJ; Morrow, PK; Page, JH; Siozon, CC	1
Barron, R; Chandler, DB; Fust, K; Li, X; Lyman, GH; Maschio, M; Parthan, A; Walli-Attaei, M; Weinstein, MC	1
Di, BS; Ge, L; Huang, WH; Li, Y; Tian, JH; Wei, KP; Xiao, XJ; Yang, KH; Yu, Q; Zhang, FW; Zhang, XH	1
Assi, H; Boyle, L; Murray, J; Rayson, D	1
Inokuchi, J; Kiyoshima, K; Naito, S; Shiota, M; Takeuchi, A; Tatsugami, K; Yokomizo, A	1
Hasegawa, S; Kikuchi, E; Kosaka, T; Miyajima, A; Mizuno, R; Morita, S; Nagata, H; Nakagawa, K; Oya, M; Shigeta, K; Shinoda, K; Yasumizu, Y; Yazawa, S	1
Allcott, K; Pettengell, R; Pfeil, AM; Schwenkglenks, M; Szabo, Z; von Minckwitz, G	1
DePoint Christensen, R; Havsteen, H; Herrstedt, J; Kristensen, G; Lund, B; Maenpaa, J; Mirza, MR; Wang, Y	1
Gilbar, P; McPherson, I; Sorour, N	1
Bias, P; Bondarenko, IM; Buchner, A	1
Rayson, D; Skedgel, C; Younis, T	1
Bias, P; Buchner, A; Elsässer, R; Gladkov, OA; Müller, U	1
Galsky, MD; Oh, WK; Tsao, CK	1
Capelan, M; Lote, H; Mohammed, K; Papadimitraki, E; Redana, S; Ring, A; Sharp, A	1

Reviews

3 review(s) available for docetaxel anhydrous and Chemotherapy-Induced Febrile Neutropenia

Article	Year
Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature. BMC cancer, 2019, Dec-16, Volume: 19, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aortitis; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Female; Fever; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Trastuzumab	2019
Effectiveness and safety of pemetrexed versus docetaxel as a treatment for advanced non-small cell lung cancer: a systematic review and meta-analysis. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:8 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy-Induced Febrile Neutropenia; Disease-Free Survival; Docetaxel; Glutamates; Guanine; Humans; Lung Neoplasms; Pemetrexed; Taxoids; Treatment Outcome	2014
Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:2 Topics: Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasms; Polyethylene Glycols; Recombinant Fusion Proteins; Recombinant Proteins; Serum Albumin; Serum Albumin, Human; Taxoids	2015

Trials

5 trial(s) available for docetaxel anhydrous and Chemotherapy-Induced Febrile Neutropenia

Article	Year
Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer. BMC cancer, 2021, Oct-01, Volume: 21, Issue:1 Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Fatigue; Feasibility Studies; Female; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Oxonic Acid; Patient Compliance; Stomach Neoplasms; Tegafur	2021
Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:10 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy-Induced Febrile Neutropenia; Disease Progression; Docetaxel; Female; Filgrastim; Humans; Lung Neoplasms; Male; Middle Aged; Polyethylene Glycols; Ramucirumab	2020
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer. BMC cancer, 2014, Dec-11, Volume: 14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Ovarian Epithelial; Chemotherapy-Induced Febrile Neutropenia; Disease Progression; Disease-Free Survival; Docetaxel; Drug Screening Assays, Antitumor; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Somatosensory Disorders; Taxoids; Treatment Outcome; Young Adult	2014
Incidence of bone pain in patients with breast cancer treated with lipegfilgrastim or pegfilgrastim: an integrated analysis from phase II and III studies. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Back Pain; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Double-Blind Method; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Male; Middle Aged; Musculoskeletal Pain; Myalgia; Polyethylene Glycols; Recombinant Proteins; Taxoids	2016
Chemotherapy-associated treatment burden in breast cancer patients receiving lipegfilgrastim or pegfilgrastim: secondary efficacy data from a phase III study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:1 Topics: Administration, Cutaneous; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Cost of Illness; Critical Care; Docetaxel; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Length of Stay; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Risk Factors; Taxoids	2016

Other Studies

21 other study(ies) available for docetaxel anhydrous and Chemotherapy-Induced Febrile Neutropenia

Article	Year
Predictive Factors of Febrile Neutropenia After Primary Prophylactic Pegfilgrastim With DCF Chemotherapy for Esophageal Cancer. Anticancer research, 2022, Volume: 42, Issue:12 Topics: Aged; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Retrospective Studies	2022
Chemotherapy-induced febrile neutropenia: primary G-CSF prophylaxis indicated during docetaxel cycles. The Netherlands journal of medicine, 2019, Volume: 77, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Netherlands; Retrospective Studies	2019
The effects of advanced age and serum α British journal of clinical pharmacology, 2017, Volume: 83, Issue:11 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Orosomucoid; Prospective Studies; Taxoids	2017
The timing of docetaxel initiation in metastatic castrate-sensitive prostate cancer and the rate of chemotherapy-induced toxicity. Medical oncology (Northwood, London, England), 2019, Jan-21, Volume: 36, Issue:2 Topics: Aged; Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Retrospective Studies	2019
Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients. Anticancer research, 2019, Volume: 39, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; C-Reactive Protein; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hyponatremia; Incidence; Induction Chemotherapy; Inflammation Mediators; Japan; Lymphocyte Count; Male; Middle Aged; Nutritional Status; Platelet Count; Predictive Value of Tests; Retrospective Studies; Risk Factors; Serum Albumin, Human; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome	2019
Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia. European journal of cancer care, 2019, Volume: 28, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Docetaxel; Emergencies; Female; Fever; Hospitalization; Humans; Infections; Kaplan-Meier Estimate; Logistic Models; Mastectomy; Mastectomy, Segmental; Middle Aged; Neutropenia; New South Wales; Odds Ratio; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Rate; Trastuzumab	2019
Risk factors for febrile neutropenia in neoadjuvant docetaxel, cisplatin, and 5-fluorouracil chemotherapy for esophageal cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:4 Topics: Adult; Age Factors; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Male; Middle Aged; Neoadjuvant Therapy; Residence Characteristics; Retrospective Studies; Risk Factors	2020
Full-dose chemotherapy in early stage breast cancer regardless of absolute neutrophil count and without G-CSF does not increase chemotherapy-induced febrile neutropenia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Staging; Neutrophils; Retrospective Studies; Risk Factors; Taxoids	2013
Incidence and predictors of febrile neutropenia during chemotherapy in patients with head and neck cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Incidence; Japan; Male; Middle Aged; Retrospective Studies; Risk Factors; Taxoids	2013
Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients: paving the way for OMICs in low and middle income countries. Omics : a journal of integrative biology, 2013, Volume: 17, Issue:7 Topics: Antibodies, Monoclonal, Humanized; Breast Neoplasms; Case-Control Studies; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Female; Genetic Predisposition to Disease; Genotype; Global Health; Humans; Inactivation, Metabolic; Lebanon; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Poverty; Taxoids; Trastuzumab	2013
Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients. The Annals of pharmacotherapy, 2014, Volume: 48, Issue:4 Topics: Aged; Anecdotes as Topic; Antineoplastic Agents; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Drugs, Generic; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Retrospective Studies; Taxoids	2014
Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Medical Audit; Middle Aged; Retrospective Studies; Risk Factors; Taxoids; Young Adult	2014
Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin's lymphoma. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:8 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polyethylene Glycols; Prednisone; Recombinant Proteins; Risk Factors; Rituximab; Taxoids; Vincristine; Young Adult	2014
Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer. Gynecologic oncology, 2014, Volume: 133, Issue:3 Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Chemotherapy-Induced Febrile Neutropenia; Cost-Benefit Analysis; Docetaxel; Drug Costs; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Markov Chains; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polyethylene Glycols; Quality-Adjusted Life Years; Recombinant Proteins; Taxoids; Topotecan	2014
Incidence of febrile neutropenia in early stage breast cancer patients receiving adjuvant FEC-D treatment. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:12 Topics: Adjuvants, Pharmaceutic; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Canada; Chemoprevention; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Middle Aged; Neoplasm Staging; Retrospective Studies; Risk Factors; Taxoids	2014
Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:12 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Drug Monitoring; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Japan; Male; Middle Aged; Patient Selection; Prednisone; Prognosis; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Risk Factors; Severity of Illness Index; Taxoids; Treatment Outcome	2014
Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer. International journal of clinical oncology, 2015, Volume: 20, Issue:3 Topics: Age Factors; Aged; Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Humans; Male; Middle Aged; Neutropenia; Prostatic Neoplasms, Castration-Resistant; Radiotherapy; Risk Factors; Taxoids	2015
Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens for breast cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:3 Topics: Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Australia; Breast Neoplasms; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cyclophosphamide; Docetaxel; Drugs, Investigational; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Retrospective Studies; Taxoids; Trastuzumab	2015
Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Cyclophosphamide; Decision Support Techniques; Docetaxel; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Primary Prevention; Quality-Adjusted Life Years; Risk Factors; Taxoids	2016
Docetaxel for Metastatic Hormone-sensitive Prostate Cancer: Urgent Need to Minimize the Risk of Neutropenic Fever. European urology, 2016, Volume: 70, Issue:5 Topics: Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Randomized Controlled Trials as Topic; Taxoids	2016
Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population. Breast (Edinburgh, Scotland), 2016, Volume: 30 Topics: Acute Coronary Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Incidence; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pulmonary Embolism; Retrospective Studies; Risk Factors; Sentinel Lymph Node Biopsy; Stroke; Taxoids; Thromboembolism; Venous Thrombosis	2016